不同体重指数水平初次全膝关节置换术患者的90天费用、再手术和再入院情况
该回顾性研究比较了非肥胖至超重度肥胖六个BMI队列初次全膝关节置换术患者的90天费用与结局,发现病态肥胖和超重度肥胖队列90天费用显著更高,再入院费用是主要驱动因素,但3年时功能改善评分相似,超重度肥胖队列感染性翻修率显著更高。
要点
- 病态肥胖(40-49.9)和超重度肥胖(50+)队列90天费用显著高于较小BMI队列。
- 再入院费用是90天费用增加的主要驱动因素。
- 超重度肥胖队列感染性翻修率显著高于其他队列(6.2% vs 0.8-3.1%)。
核心结论
- 仅基于经济成本的医疗政策可能使病态肥胖和超重度肥胖患者面临失去关节置换治疗的风险,从而剥夺他们获得相当生活质量改善的机会。
研究设计与样本
- 回顾性审查2006年至2013年机构数据库中的全膝关节置换术患者,随访至少3年。
- 识别65例超重度肥胖患者,其他五个队列按2:1比例随机选取,总样本n=715。
主要发现
- 病态肥胖队列90天费用为$11,568 ± $1,960,超重度肥胖队列为$14,021 ± $7,903,均显著高于较小BMI队列的$9,938 - $10,352。
- 再入院费用增加是90天费用增加的主要驱动因素。
- 膝关节协会评分、SF-12心理健康综合评分和WOMAC评分的变化值在所有BMI队列间相似,但SF-12身体健康综合评分不相似。
- 中期随访时,重复手术或无菌性翻修率无统计学差异。
- 超重度肥胖队列感染性翻修率显著高于其他队列(6.2% vs 0.8-3.1%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We compared 90-day costs and outcomes for primary total knee arthroplasty patients among nonobese (body mass index [BMI] 18.5-24.9), overweight (25-29.9), obese (30-34.9), severely obese (35-39.9), morbidly obese (40-49.9), and super-obese (50+) cohorts. METHODS: We conducted a retrospective review of an institutional database of total knee arthroplasty patients from 2006 to 2013 with a minimum of 3-year follow-up. Sixty-five super-obese patients were identified, and five other cohorts were randomly selected in a 2:1 ratio (total, n = 715). Demographics, 90-day outcomes (costs, reoperations, and readmissions), and outcomes after 3 years (revisions and change scores for Short-Form Health Survey [SF-12], Knee Society Scores, and Western Ontario and McMaster Universities Arthritis Index) were aggregated. RESULTS: The 90-day costs were significantly greater in the morbidly obese ($11,568 ± $1,960) and super-obese ($14,021 ± $7,903) cohorts relative to the smaller BMI cohorts ($9,938 - $10,352). The increased cost from readmissions was the main driver of costs. The outcome change scores were similar across all the BMI cohorts for Knee Society Scores, SF-12 Mental Health Composite Score, and Western Ontario and McMaster Universities Arthritis Index, but not for the SF-12 Physical Health Composite Score. At the midterm follow-up, there was no statistical difference in repeat surgery or aseptic revision rates. Septic revisions were significantly greater in the super-obese cohort relative to the other cohorts (6.2% vs 0.8-3.1%). CONCLUSION: Health-care policy based purely on the economic costs may place morbidly obese and super-obese patients at risk of losing arthroplasty care, thereby denying them access to the comparable quality of life improvements.
引用
- Ponnusamy KE, Marsh JD, Somerville LE, et al. Ninety-Day Costs, Reoperations, and Readmissions for Primary Total Knee Arthroplasty Patients With Varying Body Mass Index Levels. J Arthroplasty. 2018. PMID: 29526335. doi:10.1016/j.arth.2018.02.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。